$23.68
Currently 17 wall-street analysts regularly analyze the financials of Viking Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Viking Therapeutics, Inc. (VKTX) have a share price target of $92.29. This median of share price forecast represents a 289.76% upside from the latest price of $23.68 as on 17.09.25.
As per the chart shown above, analysts believe that the Viking Therapeutics, Inc. (VKTX) share price will touch around $92.29 in next 12-months.
Below is a chart showing the percentage difference between Viking Therapeutics, Inc.'s share price and its median forecast price. As on 17.09.25, the difference is -63.19%
Based on 17 analysts tracking and researching Viking Therapeutics, Inc. (VKTX) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 8 | 8 | 8 |
Outperform | 7 | 8 | 8 |
Hold | 1 | 1 | 1 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |